Ahead of World Obesity Day, we examine the impact of the game-changing drugs that control appetite. Increasingly being taken ...
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
Lars Fruergaard Jørgensen is a CEO who didn't want to be CEO but under his tenure Novo Nordisk, which makes Ozempic, has ...
The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results